BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

April 1, 2023

Primary Completion Date

December 31, 2023

Study Completion Date

June 30, 2024

Conditions
Prostate CancerProstatectomyErectile Dysfunction Following Radical ProstatectomyIncontinence, Urinary
Interventions
BIOLOGICAL

BioDFence G3

Placement of a sheet of BioDFence® G3 will be applied to the neurovascular bundle on participants undergoing an elective Full Nerve Sparing Radical Prostatectomy for primary treatment of prostate cancer.

Trial Locations (1)

34747

AdventHealth, Celebration

Sponsors
All Listed Sponsors
collaborator

Integra LifeSciences Corporation

INDUSTRY

lead

AdventHealth

OTHER

NCT05363644 - BioDFence® G3 For Full Nerve-Sparing Robotic-Assisted Radical Prostatectomy | Biotech Hunter | Biotech Hunter